The Global Condom Market Outlook for the forecast period of 2026–2032 projects that the market, valued at USD 14.2 billion in 2025, is set to reach USD 25.8 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 8.9%. Key drivers for this robust growth include rising awareness of sexual health and contraception, escalating prevalence of STIs and HIV/AIDS, and comprehensive government health campaigns. The report highlights North America as the prominent region and notes significant market trends such as eco-friendly product development, advanced material innovation, and the rapid rise of e-commerce distribution for discreet purchases, despite facing competition from alternative contraceptives. Continue reading
Tag Archives: Prevention of HIV/AIDS
Cheap copies of GSK’s HIV prevention drug could be ready in 2026
LONDON, July 28 (Reuters) – British drugmaker GSK (GSK.L) has struck a deal to allow low-cost generic versions of its long-acting HIV preventive medicine to be used in the developing world, including sub-Saharan Africa where the virus remains a leading cause of death.
